Lilly's Diabetic Neuropathy Agent Ruboxistaurin Will Be Called Arxxant
Lilly is proposing to market the diabetic peripheral neuropathy agent ruboxistaurin under the trade name Arxxant
Lilly is proposing to market the diabetic peripheral neuropathy agent ruboxistaurin under the trade name Arxxant